FindMyKOL

David Wang, MD

Enriched profile

GI medical oncologist · University of Michigan

ORCIDNone on fileNPI↗
✓ Itemized profile
Region🇺🇸 Ann Arbor, MI · Midwest · United StatesSpecialtyMedical OncologyFocusGastroesophageal Cancer+3
Active KOLFindMyKOL type: RegionalLatest publicationNone indexedOnline presenceNone verifiedPayments2022–2025NIH funding2024–2025Why? →

David Wang is GI medical oncologist at University of Michigan. ClinicalTrials.gov lists 6 registered studies with this person as an investigator.

Data verified 13 Nov 2026

Overview

Updated 13 Nov 2026

David Wang, MD, is GI medical oncologist at University of Michigan. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 4 companies, 1 NIH-funded awards (2024–2025).

  • Top research focus: Gastroesophageal Cancer
  • 6 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 4 companies

Generated from the cited public record · current as of 13 Nov 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Gastroesophageal Cancer3 trialsCarcinoma, Squamous Cell2 trialsBarrett Esophagus1 trialEsophageal Neoplasms1 trialEsophageal Squamous Cell Carcinoma1 trialHypertension1 trial

Research focus

OpenAlex concept fingerprint
Gastroesophageal CancerCarcinoma, Squamous CellEsophageal NeoplasmsEsophageal Squamous Cell Carcinoma

Drugs & molecules

across trials, industry payments and publications
Lenvimageneric · LenvatinibClinical trials—Industry payments3Publications—Xtandigeneric · EnzalutamideClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Eisai Inc.Clinical trials—Industry payments3Astellas Pharma US IncClinical trials—Industry payments2Dallas VA Medical CenterClinical trials2Industry payments—Janssen Research & Development, LLCClinical trials—Industry payments1MegaPro Biomedical Co. Ltd.Clinical trials1Industry payments—National Cancer Institute (NCI)Clinical trials1Industry payments—Novartis Pharmaceuticals CorporationClinical trials—Industry payments1OSF Healthcare SystemClinical trials1Industry payments—VA Office of Research and DevelopmentClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓

Research metrics need a complete publication history and a confident author match. We omit them when either check fails. Why? →

Clinical & industry

trials, payments and federal funding
6clinical trials

Investigator role on registered studies.

View trials ↓
4companies · 2022–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 2024–2025

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 13 Nov 2026

Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:

All 6 trial records: search, sort and filter.Explore →

Industry payments

Updated 13 Nov 2026

4 companies reported payments to CMS in program years 2022–2025. These are public disclosures, not judgments. The latest:

All 5 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

NIH funding

Updated 13 Nov 2026

1 NIH research award on record, funded 2024–2025 per NIH RePORTER. The latest:

All 111 award records: search, sort and filter.Explore →

Publications

None on file yet. We only list publications we can confidently match to this person. Why? →

Background & recognition

Updated 13 Nov 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.